drugset / Trial / NCT00189267

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

NCT00189267

Phase 2 Completed 45 enrolled MEDA Pharma GmbH & Co. KG
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare effectiveness and safety of multiple applications of imiquimod 5% cream and vehicle cream in graft recipients suffering from actinic keratosis.

Timeline

Start
2002-11
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 %

Indications